InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.490
+0.010 (0.68%)
At close: Jun 13, 2025, 4:00 PM
1.400
-0.090 (-6.04%)
After-hours: Jun 13, 2025, 7:35 PM EDT

InterCure Statistics

Total Valuation

InterCure has a market cap or net worth of $71.83 million. The enterprise value is $108.90 million.

Market Cap 71.83M
Enterprise Value 108.90M

Important Dates

The last earnings date was Thursday, May 1, 2025, after market close.

Earnings Date May 1, 2025
Ex-Dividend Date n/a

Share Statistics

InterCure has 47.16 million shares outstanding. The number of shares has increased by 0.65% in one year.

Current Share Class 47.16M
Shares Outstanding 47.16M
Shares Change (YoY) +0.65%
Shares Change (QoQ) -7.94%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 27.30M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.10
Forward PS 0.18
PB Ratio 0.66
P/TBV Ratio 1.52
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.66
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.53.

Current Ratio 1.73
Quick Ratio 0.96
Debt / Equity 0.53
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -4.26

Financial Efficiency

Return on equity (ROE) is -17.03% and return on invested capital (ROIC) is -8.71%.

Return on Equity (ROE) -17.03%
Return on Assets (ROA) -7.09%
Return on Invested Capital (ROIC) -8.71%
Return on Capital Employed (ROCE) -16.40%
Revenue Per Employee $204,923
Profits Per Employee -$58,166
Employee Count 320
Asset Turnover 0.31
Inventory Turnover 1.74

Taxes

Income Tax -3.99M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -38.93% in the last 52 weeks. The beta is 0.58, so InterCure's price volatility has been lower than the market average.

Beta (5Y) 0.58
52-Week Price Change -38.93%
50-Day Moving Average 1.48
200-Day Moving Average 1.61
Relative Strength Index (RSI) 46.46
Average Volume (20 Days) 7,441

Short Selling Information

The latest short interest is 16,508, so 0.04% of the outstanding shares have been sold short.

Short Interest 16,508
Short Previous Month 12,991
Short % of Shares Out 0.04%
Short % of Float 0.06%
Short Ratio (days to cover) 1.78

Income Statement

In the last 12 months, InterCure had revenue of $65.58 million and -$18.61 million in losses. Loss per share was -$0.41.

Revenue 65.58M
Gross Profit 11.55M
Operating Income -24.13M
Pretax Income -15.91M
Net Income -18.61M
EBITDA -21.48M
EBIT -24.13M
Loss Per Share -$0.41
Full Income Statement

Balance Sheet

The company has $21.59 million in cash and $58.04 million in debt, giving a net cash position of -$36.45 million or -$0.77 per share.

Cash & Cash Equivalents 21.59M
Total Debt 58.04M
Net Cash -36.45M
Net Cash Per Share -$0.77
Equity (Book Value) 109.18M
Book Value Per Share 2.31
Working Capital 45.32M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.37 million and capital expenditures -$1.20 million, giving a free cash flow of -$19.81 million.

Operating Cash Flow -18.37M
Capital Expenditures -1.20M
Free Cash Flow -19.81M
FCF Per Share -$0.42
Full Cash Flow Statement

Margins

Gross margin is 17.61%, with operating and profit margins of -36.80% and -28.38%.

Gross Margin 17.61%
Operating Margin -36.80%
Pretax Margin -36.56%
Profit Margin -28.38%
EBITDA Margin -32.75%
EBIT Margin -36.80%
FCF Margin n/a

Dividends & Yields

InterCure does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.65%
Shareholder Yield -0.65%
Earnings Yield -25.91%
FCF Yield -27.59%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

InterCure has an Altman Z-Score of 0.24 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.24
Piotroski F-Score 1